Sherif Farag

  • 4164 Citations
  • 32 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Short survey

Chronic graft-versus-host disease: Where do we go from here?

Farag, S. S., Mar 1 2004, In : Bone Marrow Transplantation. 33, 6, p. 569-577 9 p.

Research output: Contribution to journalShort survey

44 Scopus citations
Review article

Biology and clinical impact of human natural killer cells

Farag, S. S., VanDeusen, J. B., Fehniger, T. A. & Caligiuri, M. A., Jul 2003, In : International Journal of Hematology. 78, 1, p. 7-17 11 p.

Research output: Contribution to journalReview article

78 Scopus citations

Chronic lymphocytic leukemia.

Kay, N. E., Hamblin, T. J., Jelinek, D. F., Dewald, G. W., Byrd, J. C., Farag, S., Lucas, M. & Lin, T., 2002, In : Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. p. 193-213 21 p.

Research output: Contribution to journalReview article

74 Scopus citations

DC therapy? Let the natural killer answer

Farag, S. S., Sep 15 2005, In : Blood. 106, 6, 1 p.

Research output: Contribution to journalReview article

1 Scopus citations

Immunotherapeutic concepts to target acute myeloid leukemia: Focusing on the role of monoclonal antibodies, hypomethylating agents and the leukemic microenvironment

Gbolahan, O. B., Zeidan, A. M., Stahl, M., Zaid, M. A., Farag, S., Paczesny, S. & Konig, H., Aug 2017, In : International journal of molecular sciences. 18, 8, 1660.

Research output: Contribution to journalReview article

15 Scopus citations
1 Scopus citations

Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect

Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A. & Caligiuri, M. A., Sep 15 2002, In : Blood. 100, 6, p. 1935-1947 13 p.

Research output: Contribution to journalReview article

400 Scopus citations

New directions in natural killer cell-based immunotherapy of human cancer

Farag, S. S., Fehniger, T. A., Becknell, B., Blaser, B. W. & Caligiuri, M. A., Apr 1 2003, In : Expert Opinion on Biological Therapy. 3, 2, p. 237-250 14 p.

Research output: Contribution to journalReview article

31 Scopus citations

Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplation in patients aged ≥ 50 years compared to young adults with low-risk disease

Farag, S. S., Elder, P. J., Marcucci, G., Penza, S., Mrozek, E., Molina, A., Lin, T., Avalos, B. R. & Copelan, E., Jan 1 2003, In : Bone marrow transplantation. 31, 2, p. 87-93 7 p.

Research output: Contribution to journalReview article

12 Scopus citations

The potential role of Aurora kinase inhibitors in haematological malignancies

Farag, S. S., Dec 2011, In : British journal of haematology. 155, 5, p. 561-579 19 p.

Research output: Contribution to journalReview article

43 Scopus citations
16 Scopus citations

Vaccine and cell-based therapeutic approaches in acute myeloid leukemia

Agrawal, V., Gbolahan, O. B., Stahl, M., Zeidan, A. M., Abu Zaid, M., Farag, S. S. & Konig, H., 2020, In : Current cancer drug targets. 20, 7, p. 473-489 17 p.

Research output: Contribution to journalReview article

Letter

Diffuse alveolar hemorrhage following gemtuzumab ozogamicin [2]

Lin, T. S., Penza, S. L., Avalos, B. R., Lucarelli, M. R., Farag, S. S., Byrd, J. C. & Copelan, E. A., Apr 2005, In : Bone marrow transplantation. 35, 8, p. 823-824 2 p.

Research output: Contribution to journalLetter

9 Scopus citations

Phase II study of topotecan and cyclophosphamide in patients with relapsed and refractory multiple myeloma

Kraut, E. H., Young, D., Farag, S., James, A. G. & Solove, R. J., Oct 1 2005, In : Leukemia Research. 29, 10, p. 1233-1234 2 p.

Research output: Contribution to journalLetter

3 Scopus citations
Conference contribution

Generation of alloreactive T-cells in-vitro for cellular therapy

Shao, M., Farag, S. & Chalmers, J., 2005, AIChE Annual Meeting, Conference Proceedings. p. 8690 1 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

The scale-up of T cell depletion for mismatched bone marrow transplants

Xiong, Y., Tong, X., Farag, S. & Chalmers, J., 2005, AIChE Annual Meeting, Conference Proceedings. p. 9145 1 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Comment/debate

Erratum: (Clinical Cancer Research (September 2002) (2812-2819))

Farag, S. S., Nov 1 2002, In : Clinical Cancer Research. 8, 11, 1 p.

Research output: Contribution to journalComment/debate

Killer Cell Immunoglobulin-Like Receptor Ligand Mismatching: To Match or Mismatch?

Farag, S. S., Feb 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 2, p. 192-194 3 p.

Research output: Contribution to journalComment/debate

3 Scopus citations
Chapter

Cord Blood Hematopoietic Cell Transplantation

Broxmeyer, H. E., Farag, S. S. & Rocha, V., Jan 1 2016, Thomas' Hematopoietic Cell Transplantation: Fifth Edition. Wiley-Blackwell, Vol. 1-2. p. 437-455 19 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

13 Scopus citations

Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma

Farag, S. S. & Caligiuri, M. A., Dec 1 2004, Treatment of Leukemia and Lymphoma. p. 295-318 24 p. (Advances in Pharmacology; vol. 51).

Research output: Chapter in Book/Report/Conference proceedingChapter

23 Scopus citations

Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation

Ruggeri, L., Zhang, S. & Farag, S. S., Oct 15 2009, Hematopoietic Stem Cell Transplantation. Bishop, M. (ed.). p. 47-69 23 p. (Cancer Treatment and Research; vol. 144).

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations
Article

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation

Hamadani, M., Hofmeister, C. C., Jansak, B., Phillips, G., Elder, P., Blum, W., Penza, S., Lin, T. S., Klisovic, R., Marcucci, G., Farag, S. S. & Devine, S. M., Jul 1 2008, In : Biology of Blood and Marrow Transplantation. 14, 7, p. 783-789 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation

Tong, X., Xiong, Y., Zborowski, M., Farag, S. S. & Chalmers, J. J., Oct 2007, In : Experimental Hematology. 35, 10, p. 1613-1622 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Antimyeloma effects of a sesquiterpene lactone parthenolide

Suvannasankha, A., Crean, C. D., Shanmugam, R., Farag, S. S., Abonour, R., Boswell, H. S. & Nakshatri, H., Mar 15 2008, In : Clinical Cancer Research. 14, 6, p. 1814-1822 9 p.

Research output: Contribution to journalArticle

32 Scopus citations

Aphase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., Caligiuri, M. A. & Farag, S. S., Nov 22 2012, In : Blood. 120, 22, p. 4324-4333 10 p.

Research output: Contribution to journalArticle

147 Scopus citations

A phase I trial of flavopiridol in relapsed multiple myeloma

Hofmeister, C. C., Poi, M., Bowers, M. A., Zhao, W., Phelps, M. A., Benson, D. M., Kraut, E. H., Farag, S., Efebera, Y. A., Sexton, J., Lin, T. S., Grever, M. & Byrd, J. C., Feb 2014, In : Cancer Chemotherapy and Pharmacology. 73, 2, p. 249-257 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R. P., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. J. & Farag, S. S., Jul 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Aurora kinase A inhibitor protein kinase inhibitor oncolytic

Zhang, S. & Farag, S., 2011, In : Drugs of the Future. 36, 1, p. 5-15 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

Autologous and allogeneic hematopoietic stem cell transplantation (HCT) in multiple myeloma (MM): a single institution experience

Farag, S. S., Hike, S., Elder, P. J., Marcucci, G., Penza, S. L., Mrozek, E., Avalos, B. R. & Copelan, E. A., Dec 1 2000, In : Blood. 96, 11 PART II, p. 354b

Research output: Contribution to journalArticle

16 Scopus citations

Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

Jing, Y., Moore, L. R., Williams, P. S., Chalmers, J. J., Farag, S. S., Bolwell, B. & Zborowski, M., Apr 15 2007, In : Biotechnology and Bioengineering. 96, 6, p. 1139-1154 16 p.

Research output: Contribution to journalArticle

88 Scopus citations
2 Scopus citations

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission

Farag, S. S., Maharry, K., Zhang, M. J., Pérez, W. S., George, S. L., Mrózek, K., DiPersio, J., Bunjes, D. W., Marcucci, G., Baer, M. R., Cairo, M., Copelan, E., Cutler, C. S., Isola, L., Lazarus, H. M., Litzow, M. R., Marks, D. I., Ringdén, O., Rizzieri, D. A., Soiffer, R. & 4 others, Larson, R. A., Tallman, M. S., Bloomfield, C. D. & Weisdorf, D. J., Dec 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 12, p. 1796-1803 8 p.

Research output: Contribution to journalArticle

81 Scopus citations

Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

Lara, O., Tong, X., Zborowski, M., Farag, S. S. & Chalmers, J. J., May 5 2006, In : Biotechnology and Bioengineering. 94, 1, p. 66-80 15 p.

Research output: Contribution to journalArticle

27 Scopus citations

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Khawaja, M. R., Perkins, S. M., Schwartz, J. E., Robertson, M. J., Kiel, P. J., Sayar, H., Cox, E. A., Vance, G. H., Farag, S. S., Cripe, L. D. & Nelson, R. P., Feb 1 2015, In : American Journal of Hematology. 90, 2, p. 97-99 3 p.

Research output: Contribution to journalArticle

Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer

Farag, S. S., Green, M. D., Morstyn, G., Sheridan, W. P. & Fox, R. M., Jan 1 1992, In : Annals of internal medicine. 116, 6, p. 473-478 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Differential action of diffusible molecules in long‐term marrow culture on proliferation of leukaemic and normal haemopoietic cells

Firkin, F. C., Birner, R. & Farag, S., May 1993, In : British journal of haematology. 84, 1, p. 8-15 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Differential stem-and progenitor-cell trafficking by prostaglandin e 2

Hoggatt, J., Mohammad, K. S., Singh, P., Hoggatt, A. F., Chitteti, B. R., Speth, J. M., Hu, P., Poteat, B. A., Stilger, K. N., Ferraro, F., Silberstein, L., Wong, F. K., Farag, S. S., Czader, M., Milne, G. L., Breyer, R. M., Serezani, C. H., Scadden, D. T., Guise, T. A., Srour, E. F. & 1 others, Pelus, L. M., Mar 21 2013, In : Nature. 495, 7441, p. 365-369 5 p.

Research output: Contribution to journalArticle

86 Scopus citations

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

Broxmeyer, H. E., Hoggatt, J., O'leary, H. A., Mantel, C., Chitteti, B. R., Cooper, S., Messina-Graham, S., Hangoc, G., Farag, S., Rohrabaugh, S. L., Ou, X., Speth, J., Pelus, L. M., Srour, E. F. & Campbell, T. B., Dec 1 2012, In : Nature Medicine. 18, 12, p. 1786-1796 11 p.

Research output: Contribution to journalArticle

129 Scopus citations

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Agrawal, V., Ranganath, P., Ervin, K. D., Schmidt, C. A., Cox, E. A., Nelson, R. P., Schwartz, J. E., Zaid, M. A., Abonour, R., Robertson, M. J., Brinda, B. J., Griffin, S. P., Thakrar, T. C. & Farag, S. S., 2020, (Accepted/In press) In : Bone marrow transplantation.

Research output: Contribution to journalArticle

Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient

Farag, S. S., Firkin, F. C., Andrew, J. H., Soon Lee, C. & Ellis, D. H., Sep 1992, In : Journal of Infection. 25, 2, p. 201-202,IN7-IN8,203-204

Research output: Contribution to journalArticle

24 Scopus citations

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia

Lin, T. S., Flinn, I. W., Modali, R., Lehman, T. A., Webb, J., Waymer, S., Moran, M. E., Lucas, M. S., Farag, S. S. & Byrd, J. C., Jan 1 2005, In : Blood. 105, 1, p. 289-291 3 p.

Research output: Contribution to journalArticle

66 Scopus citations

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Farag, S. S., Flinn, I. W., Modali, R., Lehman, T. A., Young, D. & Byrd, J. C., Feb 15 2004, In : Blood. 103, 4, p. 1472-1474 3 p.

Research output: Contribution to journalArticle

177 Scopus citations

From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

Zhang, S. & Farag, S. S., Jul 1 2011, In : Expert Opinion on Investigational Drugs. 20, 7, p. 1015-1028 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation

Blum, W., Bolwell, B. J., Phillips, G., Farag, S. S., Lin, T. S., Avalos, B. R., Penza, S. L., Marcucci, G., Byrd, J. C., Kalaycio, M. E., Sobecks, R. M., Pohlman, B., Brown, S., Elder, P. J. & Copelan, E. A., Jan 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 1, p. 61-67 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia

Farag, S. S., Bolwell, B. J., Elder, P. J., Kalaycio, M., Lin, T., Pohlman, B., Penza, S., Marcucci, G., Blum, W., Sobecks, R., Avalos, B. R., Byrd, J. C. & Copelan, E., Apr 1 2005, In : Bone Marrow Transplantation. 35, 7, p. 653-661 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Benson, D. M., Elder, P. J., Lin, T. S., Blum, W., Penza, S., Avalos, B., Copelan, E. & Farag, S. S., Aug 2007, In : Leukemia Research. 31, 8, p. 1069-1075 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S. S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

Human natural killer cell development and biology

Farag, S. S. & Caligiuri, M. A., May 1 2006, In : Blood Reviews. 20, 3, p. 123-137 15 p.

Research output: Contribution to journalArticle

327 Scopus citations

Immunologic Approaches to Acute Leukemia in the Elderly

Farag, S. S. & Caligiuri, M. A., Apr 1 2006, In : Seminars in Hematology. 43, 2, p. 118-125 8 p.

Research output: Contribution to journalArticle

10 Scopus citations